HB 884 creates a Louisiana Sexual Assault Oversight Commission within the Department of Justice, requiring it to include a member with expertise in forensic medical exams for sexual assault victims. The bill mandates the Louisiana State Police Crime Laboratory to report by March 1, 2015, on untested sexual assault kits and agencies failing to submit required reports, while defining key terms like "forensic medical examination." It also requires all licensed hospitals and healthcare providers to inform sexual assault survivors about treatment options and follow specific care procedures. This bill directly affects sexual assault survivors, healthcare providers, and criminal justice agencies by improving oversight, reporting transparency, and access to care for victims.
HB 197 establishes rules for Louisiana healthcare providers using artificial intelligence (AI). It allows AI for administrative tasks like scheduling, billing, and analyzing de-identified patient data, but prohibits AI from making treatment decisions, interacting directly with patients, or creating therapy plans without review by a licensed healthcare professional. Violations can result in civil penalties up to $10,000 per incident, with the Louisiana Department of Health empowered to investigate complaints and enforce rules. The bill directly affects all healthcare providers licensed in Louisiana who use AI tools in their practice.
HB 277 requires drug manufacturers and marketers to include specific price information in educational or promotional materials provided to healthcare providers. The bill mandates that these materials disclose the average wholesale cost for a 30-day supply (or adjusted duration for shorter treatments) and whether a biosimilar or generic alternative exists for the same condition. This directly affects pharmaceutical companies and marketing entities targeting doctors. Violations would be enforced under Louisiana’s consumer protection laws, but the bill does not regulate actual drug prices or require discounts.
SB 387 amends Louisiana law to regulate pharmacy benefit managers (PBMs), directly affecting PBMs, local pharmacies, health insurers, and patients. It establishes new definitions (like "Maximum Allowable Cost List" and "Effective rate pricing"), requires PBMs to provide transparent compensation and services to enrollees and providers, and creates a private right to sue for violations. The bill also mandates audits of PBM practices, sets penalties for noncompliance, and repeals outdated provisions. These changes aim to increase transparency and accountability in how PBMs handle prescription drug pricing and reimbursements within Louisiana.
HB 732 allows Louisiana's Motor Vehicle Office to temporarily waive outstanding fees, fines, or license suspensions for up to 30 days when a person needs immediate access to life-sustaining medical treatment due to a life-threatening condition. It directly affects individuals with delinquent debt to the Motor Vehicle Office who provide documentation from a licensed physician or medical provider verifying the emergency. The bill requires the office to issue a written decision for each waiver and specifies that the temporary suspension does not forgive the underlying debt, though the commissioner may still reduce or eliminate the obligation at their discretion. This change takes effect upon gubernatorial approval or legislative override of a veto.
HB 935 amends Louisiana's TOPS scholarship program to allow students who complete undergraduate degrees early (in under eight semesters) to continue receiving full scholarship benefits for graduate medical sciences programs. It applies only to nonpublic colleges or universities that meet four specific criteria: offering graduate medical sciences programs, being physically collocated with a public university since 2020, billing tuition through that public institution, and not being part of Louisiana's independent colleges association. Students must maintain academic standards to retain the award. This policy change expands TOPS coverage to graduate medical education at qualifying institutions without altering the core scholarship structure.
HB 742 removes a requirement that applicants for the Family Independence Temporary Assistance Program and Medicaid must have certain immunizations. The bill repeals specific sections of Louisiana law (R.S. 46:231.4 and Section 13 of Act No. 478) that previously mandated these vaccinations for program eligibility. It directs the Department of Children and Family Services and the Louisiana Department of Health to update their rules to align with this change. This policy change directly affects individuals applying for these two public assistance programs by eliminating a vaccination prerequisite.
SB 242 amends Louisiana law to clarify definitions and requirements for home health agency licensure under the Louisiana Department of Health. It defines "home health aide services" as semi-skilled assistance with at least two daily living tasks, vital sign monitoring, and written reporting to healthcare professionals. The bill requires home health agencies to disclose any financial or familial ties to other home health providers when applying for or renewing their license. This directly affects home health agencies operating in Louisiana, mandating clearer service standards and transparency in ownership relationships. The bill is currently pending review by the Health and Welfare Committee.
SB 310, the "Signs of Hope Act," requires all public high school and college/university student health centers in Louisiana to display specific signs about pregnancy resources. The signs must read "Pregnant? Help Is Available for You and Your Baby!" with a website link to Louisiana Department of Health pregnancy resources, measure at least 16x20 inches, use large readable text, and include color graphics. These signs must be placed in patient admission areas, waiting rooms, and consultation rooms by health center staff. The Louisiana Department of Health designs the signs but may accept donated signs or use donated funds to cover costs, without requiring state funds.
HB 475 requires healthcare providers in Louisiana to obtain a patient's verbal consent before using artificial intelligence to transcribe medical appointments or treatments. If a patient declines consent, providers must conduct the appointment without AI transcription. This bill directly affects licensed healthcare professionals and their patients by establishing a clear consent process for AI-assisted documentation. The key provision mandates that providers cannot use AI transcription tools without explicit patient agreement, with an opt-out option ensuring no forced use of the technology. The legislation focuses solely on the consent requirement for AI transcription, not general recording practices.
